Miss D
ProPublicaWhen I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.
KevinOnEarth@ProPublica
I'm surprised that insurers & employers are OK with the costs of pharmaceuticals in the US.
...Unless they have something to gain themselves. 🤔
I'm surprised that insurers & employers are OK with the costs of pharmaceuticals in the US.
...Unless they have something to gain themselves. 🤔
sandywb14@ProPublica So the CEOs of drug companies are comfortable with this? What a lack of humanity.
baconandcoconut@Sandywb @ProPublica They're all ghouls. We've created a pharmaceutical industry full of sociopaths who giddily observe the desperation of cancer patients and their families. I hope one day we have the courage to prosecute these killers.
@baconandcoconut @ProPublica I hope there’s a hell.
ProScience 🇪🇺Please name the individuals who you've experienced to act like this.
@proscience I live in the US and experience the barriers and cost cutting mentality almost every time I interact with medical billing
That's by no means an answer to my request.
Note that I do not defend the prices. Not the slightest bit.
I just seek evidence for the claims in the post I initially responded to because if you can't, you're—sorry—no better than Trumpists who spread falsehoods.
Kevin Cheek@baconandcoconut I already blocked them, but I recommend ignoring Proscience. They're being a jackass throwing out logical fallacies and then declaring victory. Defending ghouls makes one a ghoul or at least a ghoul-sympathizer.
Their challenge is clearly answered in the article as a specific case study, with names. I guess it was too much to ask that someone read the article before being a dick to someone whose comments are clearly aligned with obvious patterns in our current systems.
@baconandcoconut The largest and most profitable healthcare-related corporations behave in obviously exploitive ways that bankrupt and kill patients.
Propublica, NPR, etc. have huge numbers of articles and case studies similar to this one (with plenty of names of responsible individuals). Pharma Bro is a caricature of these ghoulish clowns, but only because he's one of the more flamboyant and unapologetic ones. He's cut from exactly the same sociopathic cloth as the rest.
@baconandcoconut btw, my new blocked friend reminds me of the joke my parents would tell about the kid who doesn't want to eat his vegetables. The kid's parents told him "you're lucky to have food, there are many children starving around the world!" The kid replies "Name two".
It's an obvious joke that points out the logical fallacy of blocked friend's attempt to delegitimize the very valid point being made.
@kcheek I was 90% sure that ask was in bad faith but every so often I encounter people from outside the US who don't know how truly monstrous health care here is
Robin Barton@ProPublica I think it is a technical concept call obscene profits?
CurtAdams@ProPublica Wow, what a horrifying story about abuse of patent laws. California has talked about manufacturing its own versions of immorally overpriced drugs, and I think it should start making this one yesterday.
llanciawn@ProPublica It's a scam. All insurance is the root of scams. The drug companies get away with it because of insurance.
Cookiefiend@ProPublica My thanks to David Armstrong for this article. My husband has been taking Revlimid since 2011. We too thought the cost would drop when there was a generic...but no. I hate Celgene and its successor company so much.
@LPerry2 @ProPublica My sincere sympathies! I wish you only the best in that horrific battle. Much love to you and your husband. I'm so sorry we have this exploitive and cruel system that takes advantage of people's misfortune. It's wrong. So very wrong.
Bill Adams@ProPublica When the government allows companies to levy a private tax (patent fee) on their products, they need to be very tightly controlled and monitored. This has not been the case for a very long time. Economist Dean Baker has been calling this out for many years.
Fred G@ProPublica thanks for this great article. As a patient, this really highlighted the two-faced nature of the company who also appears as a benevolent participant of research and patient support...
Jim Lillicotch@ProPublica
I have #diabetes which is not too expensive to treat, but my wife has had #MS (M$) for many years, so we both know a thing or 3 about prices & life or death negotiations about #drugs & #formularies.
I have #diabetes which is not too expensive to treat, but my wife has had #MS (M$) for many years, so we both know a thing or 3 about prices & life or death negotiations about #drugs & #formularies.
Bront@jimlil @ProPublica we could argue about the expensiveness of treating diabetes haha. Its quite bad. It may not be "as bad" as another drug, but we are all in the same boat really. We shouldnt be paying at all just to survive in the ways many abled people do. Its good light to shed on for sure. And appreciate this article.
Darren@ProPublica thanks - that’s brutal reading. As ugly as the Celgene behavior was, the response by regulators and the failure of the patent system is equally horrifying. The FTC could have stopped this at any point and they made a mockery of the bargain at the heart of patent protection. I’m sure they sleep well at night still.